BGR-34

BGR-34 (Blood Glucose Regulator-34)[1] is an Ayurvedic-derived product that is sold in India as an over-the-counter pill for the management of type 2 diabetes. It was developed in 2015 by two government-owned laboratories and launched commercially in 2016. It has been tested in only one, modest-sized, human trial.[2] The drug has been heavily criticized, and without more clinical trials, its efficacy remains unproven.[3][4][5] The manufacturers have refused to acknowledge the claims of inefficacy and other concerns.

  1. ^ Somasekhar, M. (5 February 2016). "2 years on, markets still hypo about herbal diabetes drug". @businessline. Archived from the original on 2019-01-09. Retrieved 2018-12-15.
  2. ^ Cite error: The named reference Gupta2018 was invoked but never defined (see the help page).
  3. ^ "Seven of the Fishiest 'Science' Claims Indians Made in 2016". The Wire. Archived from the original on 2018-12-18. Retrieved 2018-12-18.
  4. ^ Singh, Seema (4 November 2016). "A dubious diabetes drug, regulatory confusion, and a potential PIL". The Ken.Com.
  5. ^ Cite error: The named reference :3 was invoked but never defined (see the help page).